The Analyst Verdict: Enovix In The Eyes Of 8 Experts
The Analyst Verdict: Enovix In The Eyes Of 8 Experts
分析师意见：Enovix在8位专家眼中
During the last three months, 8 analysts shared their evaluations of Enovix (NASDAQ:ENVX), revealing diverse outlooks from bullish to bearish.
在过去的三个月里，8位分析师对Enovix（纳斯达克代码：ENVX）进行了评估，展示了从看好到看淡的不同观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $22.62, with a high estimate of $36.00 and a low estimate of $14.00. This upward trend is apparent, with the current average reflecting a 6.25% increase from the previous average price target of $21.29.
总资产回报率（ROA）：Enovix的ROA低于行业平均水平，表明从资产中获取最大回报方面存在挑战。公司ROA为-23.22％，可能会面临实现最佳财务绩效方面的障碍。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
登录免费看全文
登录/注册